Rui Avelar
Hoofd Techniek/Wetenschap/O&O bij EVOLUS, INC.
Vermogen: 5 M $ op 31-05-2024
Actieve functies van Rui Avelar
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| EVOLUS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-01-2014 | - |
Loopbaan van Rui Avelar
Eerdere bekende functies van Rui Avelar
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
AEON Biopharma Sub, Inc.
 AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | Hoofd Techniek/Wetenschap/O&O | 01-01-2014 | 01-02-2018 |
| Allergan Medical Optics | Hoofd Techniek/Wetenschap/O&O | 01-03-2011 | 01-12-2013 |
Opleiding van Rui Avelar
| University of Toronto | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 4 |
| Canada | 2 |
Operationeel
| Chief Tech/Sci/R&D Officer | 3 |
| Doctorate Degree | 1 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| EVOLUS, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
AEON Biopharma Sub, Inc.
AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | Health Technology |
| Allergan Medical Optics |
- Beurs
- Insiders
- Rui Avelar
- Ervaring
